{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-035809","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2026-09-04T21:25:28+00:00","discovered_at":"2026-09-04T21:26:00.519060+00:00","generated_at":"2026-09-04T21:26:08.343267+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PDS Biotechnology amends $6M promissory note with YA II PN, adding mandatory redemption and extended cure period","bullets":["Amendment to $6,000,000 promissory note dated June 15, 2026 with YA II PN, Ltd.","Requires weekly remittance notices for ATM proceeds and payment within 1 business day.","Extends Nasdaq listing deficiency cure period from 75 to 180 days.","New provision: 100% of net cash proceeds from non-ATM equity financings must be paid to holder within 5 business days.","Effective upon full payment of September 14, 2026 installment amount."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-035809","json":"https://secwatch.observer/filing/0001140361-26-035809.json","markdown":"https://secwatch.observer/filing/0001140361-26-035809.md","text":"https://secwatch.observer/filing/0001140361-26-035809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/0001140361-26-035809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/ef20081442_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T21:26:08.343267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}